Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Duodenum | 2 | 2019 | 479 | 1.110 |
Why?
|
Chordoma | 2 | 2019 | 392 | 1.080 |
Why?
|
Vascular Diseases | 2 | 2022 | 1152 | 0.860 |
Why?
|
Cholangitis, Sclerosing | 1 | 2022 | 159 | 0.830 |
Why?
|
Anus Diseases | 1 | 2020 | 60 | 0.790 |
Why?
|
Cholestasis | 1 | 2022 | 349 | 0.770 |
Why?
|
Idiopathic Pulmonary Fibrosis | 2 | 2021 | 404 | 0.750 |
Why?
|
Ileum | 1 | 2022 | 561 | 0.740 |
Why?
|
Stomach | 2 | 2022 | 683 | 0.730 |
Why?
|
Anal Canal | 1 | 2020 | 345 | 0.660 |
Why?
|
Asbestos | 1 | 2019 | 243 | 0.650 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2020 | 977 | 0.640 |
Why?
|
Sarcoma, Kaposi | 1 | 2019 | 357 | 0.620 |
Why?
|
Intestinal Diseases | 2 | 2022 | 502 | 0.610 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2015 | 30 | 0.580 |
Why?
|
Adenoma, Liver Cell | 1 | 2015 | 30 | 0.580 |
Why?
|
Doxycycline | 1 | 2017 | 311 | 0.570 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2015 | 33 | 0.570 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2015 | 154 | 0.560 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2019 | 373 | 0.560 |
Why?
|
Mastocytosis, Systemic | 1 | 2016 | 97 | 0.550 |
Why?
|
Gastric Mucosa | 1 | 2017 | 623 | 0.510 |
Why?
|
Complement Activation | 1 | 2015 | 466 | 0.500 |
Why?
|
Lung Neoplasms | 5 | 2020 | 12446 | 0.490 |
Why?
|
Mesothelioma | 1 | 2019 | 813 | 0.470 |
Why?
|
Complement System Proteins | 1 | 2015 | 880 | 0.450 |
Why?
|
Bone Neoplasms | 3 | 2021 | 2568 | 0.430 |
Why?
|
Lung | 6 | 2022 | 9617 | 0.420 |
Why?
|
Pneumonia | 1 | 2022 | 2071 | 0.420 |
Why?
|
Abdominal Pain | 3 | 2022 | 1046 | 0.380 |
Why?
|
Crohn Disease | 1 | 2022 | 2277 | 0.360 |
Why?
|
Occupational Exposure | 1 | 2019 | 1774 | 0.350 |
Why?
|
Influenza A Virus, H1N1 Subtype | 3 | 2020 | 463 | 0.350 |
Why?
|
Gene Silencing | 1 | 2015 | 1638 | 0.350 |
Why?
|
Giant Cell Tumor of Bone | 2 | 2021 | 124 | 0.350 |
Why?
|
Intestinal Mucosa | 2 | 2020 | 3070 | 0.300 |
Why?
|
Biopsy | 4 | 2021 | 6786 | 0.250 |
Why?
|
Liver Neoplasms | 2 | 2017 | 4092 | 0.250 |
Why?
|
Diarrhea | 2 | 2022 | 1393 | 0.250 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7497 | 0.240 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 8864 | 0.230 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 7071 | 0.230 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2019 | 757 | 0.230 |
Why?
|
Colitis, Ischemic | 1 | 2021 | 34 | 0.220 |
Why?
|
Tomography, X-Ray Computed | 3 | 2022 | 20307 | 0.220 |
Why?
|
Receptors, Virus | 2 | 2015 | 631 | 0.210 |
Why?
|
Enterocolitis | 1 | 2021 | 86 | 0.210 |
Why?
|
Duodenitis | 1 | 2020 | 21 | 0.200 |
Why?
|
Organ Preservation | 1 | 2022 | 276 | 0.200 |
Why?
|
Smooth Muscle Tumor | 1 | 2020 | 66 | 0.190 |
Why?
|
Tomography, Optical Coherence | 2 | 2022 | 2450 | 0.190 |
Why?
|
Immunohistochemistry | 7 | 2021 | 11904 | 0.190 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 17347 | 0.190 |
Why?
|
Pulmonary Alveoli | 1 | 2022 | 731 | 0.190 |
Why?
|
Humans | 38 | 2022 | 709431 | 0.180 |
Why?
|
Alkaline Phosphatase | 1 | 2022 | 896 | 0.180 |
Why?
|
Abdominal Injuries | 1 | 2022 | 352 | 0.180 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2019 | 96 | 0.180 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2022 | 629 | 0.180 |
Why?
|
Histocytochemistry | 1 | 2019 | 765 | 0.170 |
Why?
|
Chondroblastoma | 1 | 2018 | 51 | 0.170 |
Why?
|
Tracheal Neoplasms | 1 | 2019 | 127 | 0.170 |
Why?
|
Pulmonary Fibrosis | 1 | 2022 | 525 | 0.170 |
Why?
|
Comparative Genomic Hybridization | 1 | 2019 | 514 | 0.170 |
Why?
|
Electron Transport Complex I | 1 | 2018 | 150 | 0.160 |
Why?
|
Arthralgia | 1 | 2022 | 466 | 0.160 |
Why?
|
Sialic Acids | 2 | 2015 | 131 | 0.160 |
Why?
|
Adenoma, Oxyphilic | 1 | 2018 | 134 | 0.160 |
Why?
|
Interferons | 1 | 2020 | 680 | 0.160 |
Why?
|
Anus Neoplasms | 1 | 2020 | 300 | 0.150 |
Why?
|
Diagnosis, Differential | 3 | 2022 | 13362 | 0.150 |
Why?
|
DNA, Mitochondrial | 2 | 2018 | 790 | 0.150 |
Why?
|
SOXB1 Transcription Factors | 1 | 2018 | 291 | 0.150 |
Why?
|
Bronchoscopy | 1 | 2021 | 831 | 0.150 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2019 | 657 | 0.150 |
Why?
|
Cytodiagnosis | 1 | 2019 | 414 | 0.140 |
Why?
|
Prognosis | 7 | 2020 | 29148 | 0.140 |
Why?
|
Glutathione | 1 | 2018 | 629 | 0.140 |
Why?
|
Palate, Soft | 1 | 2015 | 96 | 0.140 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3740 | 0.140 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 735 | 0.140 |
Why?
|
Osteoblasts | 1 | 2021 | 1204 | 0.130 |
Why?
|
Observer Variation | 1 | 2021 | 2696 | 0.130 |
Why?
|
Chromosome Deletion | 1 | 2019 | 1383 | 0.130 |
Why?
|
Deglutition Disorders | 1 | 2019 | 565 | 0.130 |
Why?
|
Male | 22 | 2022 | 351848 | 0.130 |
Why?
|
Fever | 1 | 2022 | 1588 | 0.130 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 1867 | 0.130 |
Why?
|
Adult | 15 | 2021 | 212298 | 0.120 |
Why?
|
Aged | 14 | 2021 | 162592 | 0.120 |
Why?
|
CD4 Lymphocyte Count | 1 | 2019 | 2543 | 0.120 |
Why?
|
Viral Tropism | 1 | 2013 | 94 | 0.120 |
Why?
|
Female | 23 | 2022 | 377269 | 0.120 |
Why?
|
Bone Density Conservation Agents | 1 | 2021 | 782 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1142 | 0.120 |
Why?
|
Celiac Disease | 1 | 2020 | 751 | 0.110 |
Why?
|
Cell Lineage | 2 | 2021 | 2632 | 0.110 |
Why?
|
Bacterial Infections | 1 | 2021 | 1432 | 0.110 |
Why?
|
RNA | 1 | 2022 | 2671 | 0.110 |
Why?
|
Middle Aged | 15 | 2021 | 215428 | 0.110 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15316 | 0.110 |
Why?
|
Dyspnea | 1 | 2019 | 1238 | 0.110 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 5168 | 0.110 |
Why?
|
Hepatectomy | 1 | 2015 | 582 | 0.110 |
Why?
|
Liver Transplantation | 1 | 2022 | 2018 | 0.110 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1818 | 0.110 |
Why?
|
Young Adult | 6 | 2021 | 56163 | 0.110 |
Why?
|
Sarcoma | 1 | 2022 | 1856 | 0.110 |
Why?
|
Mycobacterium tuberculosis | 1 | 2022 | 1832 | 0.110 |
Why?
|
Adolescent | 7 | 2022 | 85327 | 0.100 |
Why?
|
Gene Deletion | 1 | 2019 | 2858 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2047 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2015 | 882 | 0.100 |
Why?
|
Aged, 80 and over | 7 | 2021 | 58752 | 0.100 |
Why?
|
Tuberculosis | 1 | 2022 | 1763 | 0.100 |
Why?
|
Influenza, Human | 1 | 2020 | 1342 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 1852 | 0.090 |
Why?
|
Mutation | 3 | 2019 | 29242 | 0.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1581 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2020 | 2603 | 0.090 |
Why?
|
Administration, Oral | 1 | 2017 | 3952 | 0.090 |
Why?
|
Societies, Medical | 1 | 2021 | 3665 | 0.090 |
Why?
|
Stomach Neoplasms | 1 | 2018 | 1284 | 0.090 |
Why?
|
Neoplasm Staging | 2 | 2020 | 11244 | 0.090 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 1332 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1575 | 0.080 |
Why?
|
Histones | 1 | 2018 | 2585 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6830 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19470 | 0.070 |
Why?
|
Skin | 1 | 2019 | 4319 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2075 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4282 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2296 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2018 | 2214 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3884 | 0.070 |
Why?
|
Virus Replication | 1 | 2013 | 2532 | 0.070 |
Why?
|
In Situ Hybridization | 2 | 2020 | 1995 | 0.070 |
Why?
|
Mitochondria | 1 | 2018 | 3651 | 0.070 |
Why?
|
Ferrets | 2 | 2015 | 182 | 0.070 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 1489 | 0.060 |
Why?
|
Orthomyxoviridae Infections | 2 | 2015 | 228 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5151 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2022 | 71151 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2018 | 4060 | 0.050 |
Why?
|
Surface-Active Agents | 1 | 2020 | 155 | 0.050 |
Why?
|
Microvilli | 1 | 2020 | 250 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6564 | 0.050 |
Why?
|
Macaca fascicularis | 1 | 2022 | 956 | 0.050 |
Why?
|
Granuloma | 1 | 2022 | 330 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15548 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2017 | 6462 | 0.050 |
Why?
|
Caspases | 1 | 2022 | 941 | 0.050 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2020 | 329 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 21874 | 0.040 |
Why?
|
Viral Load | 2 | 2020 | 3218 | 0.040 |
Why?
|
Leucovorin | 1 | 2020 | 613 | 0.040 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2019 | 98 | 0.040 |
Why?
|
Haploidy | 1 | 2018 | 155 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 401 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1268 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39394 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1632 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16295 | 0.040 |
Why?
|
Mucins | 1 | 2020 | 556 | 0.040 |
Why?
|
Endoderm | 1 | 2018 | 180 | 0.040 |
Why?
|
Autopsy | 1 | 2020 | 980 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2022 | 1937 | 0.040 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 262 | 0.040 |
Why?
|
Cyclin D1 | 1 | 2018 | 490 | 0.040 |
Why?
|
Infant | 1 | 2018 | 34274 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2020 | 3688 | 0.040 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2018 | 684 | 0.040 |
Why?
|
Fibrosis | 1 | 2022 | 1922 | 0.040 |
Why?
|
Paclitaxel | 1 | 2022 | 1631 | 0.030 |
Why?
|
Fluorouracil | 1 | 2020 | 1641 | 0.030 |
Why?
|
Child, Preschool | 1 | 2018 | 41195 | 0.030 |
Why?
|
Immunity | 1 | 2020 | 960 | 0.030 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2015 | 152 | 0.030 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2018 | 508 | 0.030 |
Why?
|
Child | 2 | 2021 | 73998 | 0.030 |
Why?
|
HIV Infections | 1 | 2019 | 15439 | 0.030 |
Why?
|
Intestine, Small | 1 | 2020 | 1235 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 750 | 0.030 |
Why?
|
Embryonic Development | 1 | 2018 | 712 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2018 | 1063 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2019 | 4020 | 0.030 |
Why?
|
Ischemia | 1 | 2022 | 1916 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2018 | 1789 | 0.030 |
Why?
|
Respiratory System | 1 | 2015 | 560 | 0.030 |
Why?
|
Risk Factors | 1 | 2019 | 70264 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2021 | 11749 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2020 | 2340 | 0.030 |
Why?
|
Hepatocytes | 1 | 2017 | 1235 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2022 | 2929 | 0.020 |
Why?
|
Animals | 5 | 2022 | 170647 | 0.020 |
Why?
|
Virulence | 1 | 2013 | 1330 | 0.020 |
Why?
|
Neutrophils | 1 | 2022 | 3865 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4325 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 6184 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 2963 | 0.020 |
Why?
|
Mice | 3 | 2022 | 80950 | 0.020 |
Why?
|
Liver | 1 | 2022 | 7629 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2018 | 3823 | 0.020 |
Why?
|
Apoptosis | 1 | 2022 | 10133 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 17087 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5774 | 0.020 |
Why?
|
Swine | 1 | 2015 | 5743 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2013 | 6768 | 0.020 |
Why?
|
Survival Rate | 1 | 2018 | 13363 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13298 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8733 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 15286 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 18883 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9584 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9857 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 23044 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11269 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 50734 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 39650 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23985 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18384 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 61963 | 0.010 |
Why?
|